Zafgen Inc. (ZFGN) had a good day on the market for Tuesday October 22 as shares jumped 5.54% to close at $0.77. About 287,571 shares traded hands on 2,021 trades for the day, compared with an average daily volume of n/a shares out of a total float of 37.37 million. After opening the trading day at $0.73, shares of Zafgen Inc. stayed within a range of $0.77 to $0.72.
With today’s gains, Zafgen Inc. now has a market cap of $28.75 million. Shares of Zafgen Inc. have been trading within a range of $11.70 and $0.63 over the last year, and it had a 50-day SMA of $n/a and a 200-day SMA of $n/a.
Zafgen Inc is a US-based biopharmaceutical company. It focuses on developing novel therapeutics that treat the underlying biological mechanisms through the methionine aminopeptidase 2, or MetAP2, pathway. The lead product candidate of the company is ZGN-1061 which is a novel fumagillin-class MetAP2 inhibitor administered by subcutaneous injection. The company operates in the business of developing novel therapeutics. The company primarily carries its business operations in the United States.
Zafgen Inc. is based out of Boston, MA and has some 38 employees. Its CEO is Jeffrey S. Hatfield.
